Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
EAGLE PHARMACEUTICALS, INC. (EGRX)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Drug Manufacturers—Specialty & Generic
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
SELL
1 Nov 2023
Tarriff Scott
CEO, Director, Officer, 10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
545,447
-3%
21,619
$13.84
$299,309.28
SELL
16 May 2023
Tarriff Scott
CEO, Director, Officer, 10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
587,311
-2%
15,000
$19.98
$299,700.00
SELL
11 May 2023
Tarriff Scott
CEO, Director, Officer, 10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
1,595,134
-2%
45,000
$20.68
$930,656.40
SELL
6 Sep 2022
Edlin Richard A.
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
22,600
-23%
6,800
$30.99
$210,732.00
SELL
24 Oct 2019
Hudson Executive Capital LP
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
732,777
-2%
16,931
$63.48
$1,074,714.80
SELL
21 Oct 2019
Hudson Executive Capital LP
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
749,708
-1%
10,616
$62.63
$664,924.40
SELL
16 Oct 2019
Hudson Executive Capital LP
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
760,324
-2%
15,544
$62.58
$972,745.44
SELL
10 Oct 2019
Hudson Executive Capital LP
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
775,868
-3%
28,038
$60.64
$1,700,256.90
SELL
7 Oct 2019
Hudson Executive Capital LP
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
803,906
-0%
6,459
$60.09
$388,119.30
SELL
17 Sep 2019
Hudson Executive Capital LP
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
810,365
-0%
100
$60.00
$6,000.00
SELL
11 Sep 2019
Hudson Executive Capital LP
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
810,465
-0%
1,312
$60.06
$78,798.94
SELL
9 May 2019
Braunstein Douglas L
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
811,777
-16%
159,223
$56.81
$9,045,973.00
SELL
1 Apr 2019
Tarriff Scott
CEO, Director, Officer, 10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
1,500,202
-1%
24,975
$50.15
$1,252,496.20
SELL
1 Mar 2019
Tarriff Scott
CEO, Director, Officer, 10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
1,537,605
-1%
24,428
$51.17
$1,250,014.80
SELL
1 Feb 2019
Tarriff Scott
CEO, Director, Officer, 10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
1,550,505
-1%
30,085
$41.54
$1,249,831.20
SELL
2 Jan 2019
Tarriff Scott
CEO, Director, Officer, 10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
1,524,362
-2%
31,569
$39.49
$1,246,763.00
SELL
5 Mar 2018
FLAUM SANDER A
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
11,374
-17%
2,340
$53.94
$126,219.59
BUY
16 Aug 2017
Meyers Pete A.
Chief Financial Officer, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
700
+100%
350
$55.45
$19,406.38
BUY
9 Aug 2017
Braunstein Douglas L
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
954,210
+2%
20,400
$49.07
$1,001,086.56
BUY
12 Jun 2017
Meyers Pete A.
Chief Financial Officer, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
350
+100%
350
$71.49
$25,020.77
BUY
19 May 2017
Pernock David
Pres. & Chief Comm. Officer, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
966
+35%
255
$79.69
$20,320.95
BUY
16 May 2017
Pernock David
Pres. & Chief Comm. Officer, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
711
+39%
200
$82.24
$16,448.00
SELL
25 Apr 2017
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
9,738
-84%
54,180
$88.38
$4,788,482.00
SELL
30 Mar 2017
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
3,584,087
-2%
91,332
$83.09
$7,589,014.00
SELL
27 Mar 2017
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
3,675,419
-2%
106,468
$83.01
$8,837,576.00
BUY
22 Mar 2017
Edlin Richard A.
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
29,400
+25%
6,000
$79.44
$476,640.00
SELL
22 Mar 2017
Krill Steven L.
EVP & Chief Scientific Officer, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
0
-100%
14,125
$81.07
$1,145,130.20
SELL
21 Mar 2017
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
3,778,087
-0%
1,200
$83.05
$99,657.00
BUY
21 Mar 2017
Pernock David
Pres. & Chief Comm. Officer, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
511
+13%
61
$83.98
$5,122.78
SELL
16 Mar 2017
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
3,779,287
-2%
100,000
$82.06
$8,206,307.50
BUY
9 Mar 2017
Pernock David
Pres. & Chief Comm. Officer, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
450
+100%
450
$77.84
$35,028.50
SELL
4 Jan 2017
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
3,879,287
-1%
65,114
$85.16
$5,545,108.50
SELL
15 Dec 2016
Krill Steven L.
EVP & Chief Scientific Officer, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
0
-100%
50,505
$76.40
$3,858,621.80
SELL
13 Dec 2016
Krill Steven L.
EVP & Chief Scientific Officer, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
0
-100%
10,000
$73.62
$736,163.00
SELL
28 Nov 2016
FLAUM SANDER A
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
11,374
-30%
5,000
$78.66
$393,300.03
SELL
23 Nov 2016
Krill Steven L.
EVP & Chief Scientific Officer, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
0
-100%
5,987
$80.00
$478,960.00
SELL
10 Nov 2016
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
3,944,401
-0%
34,486
$85.15
$2,936,604.80
SELL
7 Nov 2016
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
4,124,707
-3%
153,830
$79.29
$12,197,276.00
SELL
2 Nov 2016
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
4,181,446
-5%
245,770
$71.02
$17,455,384.00
SELL
30 Sep 2016
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
4,373,987
-0%
22,100
$70.06
$1,548,326.00
SELL
29 Sep 2016
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
4,396,087
-1%
77,900
$70.04
$5,456,116.00
SELL
21 Sep 2016
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
4,475,785
-2%
99,795
$66.17
$6,603,416.00
SELL
6 Sep 2016
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
4,572,934
-1%
70,925
$62.50
$4,432,863.00
SELL
23 Aug 2016
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
4,643,257
-0%
28,870
$63.00
$1,818,671.00
SELL
15 Aug 2016
ProQuest Investments IV, L.P.
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
4,681,627
-2%
99,795
$61.36
$6,123,170.50
SELL
12 May 2016
ProQuest Management LLC
10% Owner
EAGLE PHARMACEUTICALS, INC.
(EGRX)
41,081
-30%
17,980
$40.72
$732,061.56
SELL
1 Apr 2016
Tarriff Scott
President and CEO, Director, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
1,369,946
-2%
30,765
$40.63
$1,249,982.00
BUY
15 Mar 2016
Graves Michael
Director
EAGLE PHARMACEUTICALS, INC.
(EGRX)
1,000
+100%
1,000
$56.73
$56,730.00
SELL
1 Mar 2016
Tarriff Scott
President and CEO, Director, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
1,412,689
-1%
19,780
$63.20
$1,250,028.00
SELL
1 Feb 2016
Tarriff Scott
President and CEO, Director, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
1,433,484
-1%
18,360
$68.08
$1,249,974.20
SELL
4 Jan 2016
Tarriff Scott
President and CEO, Director, Officer
EAGLE PHARMACEUTICALS, INC.
(EGRX)
1,441,624
-0%
14,549
$85.91
$1,249,920.90
Home